11 hours AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines Zacks
ANGO registers overall strong top-line results on a pro-forma basis in second-quarter fiscal 2025, driven by strength in the Med Tech business.
XANGO registers overall strong top-line results on a pro-forma basis in second-quarter fiscal 2025, driven by strength in the Med Tech business.
X